Skin barrier as a target for the prediction, prevention, and treatment of atopic dermatitis and food allergy in infancy
Pediatric Allergy and Immunology · 2025-11 · 36 (11)
DOI: 10.1111/pai.70238 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 02.11.2025. Verfasst von Jihyun Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Food Hypersensitivity, Dermatitis, Atopic, Skin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: Lee Kun-Hee child cancer & rare disease project, Korea Disease Control and Prevention Agency.
Abstract (Originalsprache)
Atopic dermatitis (AD) and food allergy (FA) frequently manifest during infancy and share skin barrier dysfunction as a critical early pathogenic event. Recent research has elucidated structural, lipidomic, microbial, and immunologic abnormalities that compromise the skin barrier and contribute to disease onset. Filaggrin gene mutations, altered ceramide profiles, and type 2 cytokine–driven inflammation are among the key factors disrupting epidermal integrity. While AD and FA exhibit overlapping features, including elevated risk in the presence of skin barrier defects, their pathophysiologic pathways are more complicated. This review provides updated evidence on the role of the skin barrier in the pathogenesis of AD and FA. It further highlights the distinction between these conditions and discusses recent findings from birth cohorts and interventional trials. In AD, early emollient application and environmental control show limited but promising preventive effects, particularly in high‐risk infants. In FA, prevention strategies should also address the induction of oral immune tolerance through timely introduction of allergenic foods. Future research should focus on refining predictive biomarkers, validating stepwise interventions, and developing safe, barrier‐based strategies that integrate both prevention and treatment to reduce the burden of AD and FA from early life. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Seoul, Korea.
- Department of Pediatrics, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
- Department of Pediatrics, National Jewish Health, Denver, Colorado, USA.
ORCID-Profile: Jihyun Kim, Sanghee Shin, Byung Eui Kim, Kangmo Ahn
Förderung
- Lee Kun-Hee child cancer & rare disease project
- Korea Disease Control and Prevention Agency
Zitieren
APA
Kim, J., Shin, S., Kim, B. E., & Ahn, K. (2025). Skin barrier as a target for the prediction, prevention, and treatment of atopic dermatitis and food allergy in infancy. Pediatric Allergy and Immunology, 36(11). https://doi.org/10.1111/pai.70238
Vancouver
Kim J, Shin S, Kim BE, Ahn K. Skin barrier as a target for the prediction, prevention, and treatment of atopic dermatitis and food allergy in infancy. Pediatric Allergy and Immunology. 2025;36(11). doi:10.1111/pai.70238
BibTeX
@article{Kim2025,
author = {Kim, Jihyun and Shin, Sanghee and Kim, Byung Eui and Ahn, Kangmo},
title = {Skin barrier as a target for the prediction, prevention, and treatment of atopic dermatitis and food allergy in infancy},
journal = {Pediatric Allergy and Immunology},
year = {2025},
volume = {36},
number = {11},
doi = {10.1111/pai.70238}
}
EUVIMED